πŸ‡ΊπŸ‡Έ FDA
Patent

US 12071428

Indazole compounds as kinase inhibitors

granted A61PA61P35/00

Quick answer

US patent 12071428 (Indazole compounds as kinase inhibitors) held by TYRA BIOSCIENCES, INC. expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TYRA BIOSCIENCES, INC.
Grant date
Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P35/00